Sen. Bill Cassidy (R-La.) said he secured significant concessions from the Trump administration on vaccine safety that led to ...

Discover how scientists developed a COVID-19 vaccine in record time using mRNA technology, leading to improved public health ...

Hospitalizations and general "syndromic" cases were at 10+ statewide for the week. The number of reported COVID cases ...

Moderna is developing an mRNA-based vaccine for norovirus, now in Phase 3 trials, with hopes of approval by 2026 to combat ...

The Sackler family, owners of Purdue Pharma, reached a $7.4 billion settlement to resolve mass opioid litigation. The Department of Justice filed a civil lawsuit against Walgreens over allegations it ...

Shares of Moderna Inc. rose over 5% on Tuesday morning, reaching levels last seen more than a week ago, following news of a $590 million award from the U.S. Health and Human Services Department to ...

Moderna received a $590 million award from the U.S. government to speed development of a vaccine that could be used to fight ...

Moderna gains HHS backing for developing mRNA-based pandemic influenza vaccines, advancing clinical studies for up to five subtypes. Get the Real Story Behind Every Major Earnings Report Tuesday ...

Apple shares are down 1.3% after Jefferies downgraded the tech giant from Hold to Underperform and reduced the price target from $211.84 to $200.75, citing weak iPhone sales. Shares of Walgreens Boots ...

Moderna rallied 5.4% after securing $590 million from the U.S. government to hasten development of its bird flu vaccine. Advancing issues outnumbered decliners by a 4.54-to-1 ratio on the NYSE, where ...

TUESDAY, Jan. 21, 2025 (HealthDay News) -- The U.S. Department of Health and Human Services (HHS) is awarding the pharmaceutical company Moderna $590 million to continue developing a vaccine to ...